Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Instinct Bio secures $150 million equity funding to advance its regenerative medicine platform and support strategic growth initiatives. The funding will allow for accelerated development and expansion efforts.
Amount Raised
$150 Million
Round Type
Venture - Series Unknown
TokyoBiotechnologyHealth CareDescription
Instinct Bio has entered into a term sheet for an equity purchase facility that enables it to sell up to $150 million of its common stock. This facility provides the company with the ability to access capital to support its strategic initiatives. Proceeds will fund the development of its regenerative medicine platform, working capital needs, and strategic acquisitions. CEO Tomoki Nagano expressed optimism about the additional financial flexibility this approach offers.
Funding Insights
Based on industry dataWatching Instinct Bio Technical Company Holdings? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan